Impact of Incretin-Based Therapies on Adipokines and Adiponectin

Table 1

Approved forms of incretin-based medications.

	Approved forms	Mechanisms of action	Ref.
GLP-1 RA	Exenatide (exendin-4), albiglutide, liraglutide, lixisenatide, semaglutide, dulaglutide	Agonists of intrinsic incretin receptors	[13, 19]
DPP-4i	Sitagliptin, saxagliptin, vildagliptin, linagliptin	Prevent incretin inactivation by inhibition of DPP-4 enzyme	[21, 23]